(Q43721043)

26 November 2017

title

Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype (English)

1 reference

26 November 2017

0 references

4

1 reference

26 November 2017

3

Blennow K

1 reference

26 November 2017

1

Eriksson M

1 reference

26 November 2017

5

Balldin J

1 reference

26 November 2017

Berggren U

2

1 reference

26 November 2017

publication date

1 May 2001

1 reference

26 November 2017

1 reference

26 November 2017

volume

24

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

15-23

1 reference

Is monoamine oxidase activity elevated in Prader-Willi syndrome?

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Neuroendocrine evidence for reduced serotonergic neurotransmission during heavy drinking

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Effect of citalopram on alcohol intake in heavy drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Alcohol and Central Serotonin Metabolism in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

5-Hydroxyindoleacetic acid in cerebrospinal fluid in alcoholic patients under different clinical conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Hormonal, psychological, and alcohol craving changes after m-chlorophenylpiperazine administration in alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Inheritance of alcohol abuse. Cross-fostering analysis of adopted men

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Dopamine D2-receptor gene polymorphisms in scandinavian chronic alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Effect of Fluoxetine on Alcohol Consumption in Male Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

PCR detection of the TaqA RFLP at the DRD2 locus

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

The assessment of anxiety states by rating

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Dependence symptoms but no diagnosis: diagnostic 'orphans' in a 1992 national sample

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Central nervous system serotonin and personality as variables contributing to excessive alcohol consumption in non-human primates

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Fluoxetine Treatment Seems to Reduce the Beneficial Effects of Cognitive-Behavioral Therapy in Type B Alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Bromocriptine in the treatment of alcoholics with the D2 dopamine receptor A1 allele

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Neuroendocrine responses to serotonergic agents in alcoholics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Serotonin and alcohol intake, abuse, and dependence: clinical evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Zimelidine-induced variations in alcohol intake by nondepressed heavy drinkers

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

The serotonin uptake inhibitor citalopram attenuates ethanol intake

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Differential effects of viqualine on alcohol intake and other consummatory behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

The D2 dopamine receptor gene: a review of association studies in alcoholism and phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Diagnostic orphans: adolescents with alcohol symptom who do not qualify for DSM-IV abuse or dependence diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

5-HT and alcohol abuse

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Reliability of a Timeline Method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Citalopram in the treatment of alcoholism: a double-blind placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

Serotonin in early onset, male alcoholics with violent behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2801%2900137-9

7 January 2021

10.1016/S0741-8329(01)00137-9

Identifiers

DOI

1 reference

26 November 2017

1 reference